Hemab Therapeutics Holdings, Inc. press release (COAG): Q1 GAAP EPS of -$23.98. – Cash Position and Cash Runway: Cash, cash equivalents, and marketable securities totaled $163.5 million as of March 31, 2026, compared to $185.5 million as of December 31, 2025
Hemab Therapeutics Holdings, Inc. GAAP EPS of -$23.98
Hemab Therapeutics Holdings, Inc. press release (COAG): Q1 GAAP EPS of -$23.98. - Cash Position and Cash Runway: Cash, cash equivalents, and marketable securities totaled $163.5 million as of March 31, 2026, compared to $185.5 million as of December 31, 2025